IPIRA Startups

IPIRA Startups

GenoptX, LLC

Brief Description

A CRISPR-based gene editing company.

Formerly known as Syncodi.

Inventors

Jennifer Doudna, Abraham Isser Flamholz, Dana Nadler, Benjamin Oakes, David Frank Savage

Timeline 2019. Company founded.

Genocea Biosciences, Inc.

Brief Description

Genocea finds targets of T cell responses to discover and develop life-changing medicines. The company created a pipeline of novel vaccine and immunotherapy programs that stimulate the T cell arm of the immune system, which is increasingly recognized as critical to generating protective immune responses against a wide array of diseases. Genocea designs its medicines using ATLASª, a proprietary technology platform. Genocea's platform has the potential to revolutionize vaccines and immunotherapies for a range of infectious diseases, cancers and autoimmune diseases. The...

Generation Lab

Brief Description

Generation Lab provides the first and only platform that measures the effectiveness of longevity interventions to identify what works. Co-founded by pre-eminent aging and longevity researcher Dr. Irina Conboy from UC Berkeley, Generation Lab combines an easy-to-use test with proprietary techniques to definitively measure molecular disbalance that indicates aging and risk of disease before symptoms arise. The company works with clinicians who can recommend personalized interventions to increase health, wellness, and longevity; and Generation Lab uniquely measures the...

Geneditor Biosciences, Inc.

Brief Description

Geneditor Biosciences is a pre-clinical stage gene editing company focused on the treatment of rare cancers with unmet medical needs.

Inventors

Jennifer Doudna

Company Founders

Jennifer Doudna

Timeline 2021. Company founded.

Gaowei

Brief Description

Software for vehicle guidance. The company was founded by staff at UC Berkeley's Institute for Transportation Studies.

Inventors

Fanping Bu, Thomas Hessburg, Wei-Bin Zhang

Timeline 2020. Company founded

Frontier Medicines Corporation

Brief Description

Frontier Medicines was founded to develop medical treatments for currently "undruggable" diseases. The clinical stage precision medicine company pioneers medicines for genetically-defined patient populations in oncology and immunology, and plans to broaden its therapeutic focus over time. The company uses chemoproteomics - an innovative approach to chemically interrogate proteins in living systems – to discover and pharmacologically target new binding pockets (or "hotspots") on proteins, making them accessible to small-molecule drug discovery and development. The...

FLX Micro, Inc.

Brief Description

FLX Micro, Inc. manufactures silicon carbide-based microsensors. The company develops its products through silicon carbide deposition and microfabrication technology platform. Its products are used in various applications, such as automotive, energy, environmental, and manufacturing. The company was formerly known as Fiberlead, Inc.

Inventors

Di Gao, Roger Howe, Roya Maboudian

Company Founders

Mehran Mehregany

Timeline 2000. Company founded.

Fluxion Biosciences, Inc.

Brief Description

Fluxion Biosciences provides analytical, live cell analysis tools that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms in physiologically relevant micro-environments, Fluxion helps bridge the translational medicine gap by bringing research data closer to patients. Fluxion's innovative systems for live cell analysis are enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.

The company successfully introduced three...

Flux Technology

Brief Description

Developer of high selectivity composite membranes intended for chemical separations. The company's technology improved polymer membrane stability and performance by incorporating metal-organic frameworks. The membranes offered improved carbon dioxide selectivity and permeance, as well as increased robustness under harsh feed conditions, enabling clients to maximize product recovery and reduce operational footprint.

The company was co-founded by UC Berkeley Professor of Chemistry Jeffrey Long and a PhD student in his research group, Jonathan Bachman....

EZNome, Inc.

Brief Description

EZNome commercializes high-throughput mammalian genome editing technologies utilizing CRISPR ribonucleoprotein (RNP) electroporation of zygotes (CRISPR-EZ).

Inventors

Sean Chen, Lin He, Yiu-Fai Lee

Timeline 2018. Company founded.